Estimating potency for the Emax-model without attaining maximal effects

被引:39
作者
Schoemaker, RC [1 ]
van Gerven, JMA [1 ]
Cohen, AF [1 ]
机构
[1] Ctr Human Drug Res, NL-2333 CL Leiden, Netherlands
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1998年 / 26卷 / 05期
关键词
reparameterization; pharmacodynamics; Michaelis-Menten; truncated curves; parameter estimation;
D O I
10.1023/A:1023277201179
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most widely applied model relating drug concentrations to effects is the E-max model In practice, concentration-effect relationships often deviate from a simple linear relationship but without reaching a clear maximum because a further increase in concentration might be associated with unacceptable or distorting side effects. The parameters for the E-max model can only be estimated with reasonable precision if the curve shows sign of reaching a maximum, otherwise both EC50 and E-max estimates may be extremely imprecise. This paper provides a solution by introducing a new parameter (S-0) equal to E-max/EC50 that can be used to characterize potency adequately even if there are no signs of a clear maximum. Simulations are presented to investigate the nature of the new parameter and published examples are used as illustration.
引用
收藏
页码:581 / 593
页数:13
相关论文
共 17 条
[1]  
Bachman WJ, 1998, CLIN PHARMACOL THER, V63, P199
[2]  
Bates D.M., 1988, NONLINEAR REGRESSION, P103
[3]  
BEAL SL, 1994, USE NONMEM STANDARD
[4]  
Della Paschoa OE, 1998, J PHARMACOL EXP THER, V284, P460
[5]  
Dingemanse J, 1997, BRIT J CLIN PHARMACO, V44, P477, DOI 10.1046/j.1365-2125.1997.t01-1-00612.x
[6]   ON THE IDENTIFICATION OF MICHAELIS MENTEN ELIMINATION PARAMETERS FROM A SINGLE DOSE-RESPONSE CURVE [J].
GODFREY, KR ;
FITCH, WR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (02) :193-221
[7]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[8]  
HOLFORD NHG, 1992, IN VIVO STUDY DRUG S
[9]  
KENAKIN TP, 1992, IN VIVO STUDY DRUG A
[10]   COMPUTATIONAL PROBLEMS OF COMPARTMENT MODELS WITH MICHAELIS-MENTEN-TYPE ELIMINATION [J].
METZLER, CM ;
TONG, DDM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (07) :733-737